Pantoprazole ® is one of the leading proton pump inhibitors (PPIs) used in the treatment of a variety of diseases related to the upper gastrointestinal tract. However, studies have shown an increased risk of developing gastric cancer, intestinal metaplasia and hyperplasia of endocrine cells with prolonged use. In the present study, the somatic mutation and recombination test (SMART) was employed to determine the mutagenic effects of Pantoprazole on Drosophila melanogaster. Repeated treatments with Pantoprazole were performed on 72-hour larvae of the standard (ST) and high bioactivation (HB) crosses at concentrations of 2.5, 5.0, and 10.0 mM. In addition, doxorubicin (DXR) was administered at 0.4 mM, as a positive control. When administered to ST descendants, total number of spots were statistically significant at 2.5 and 5.0 mM concentrations. For HB descendants, a significant increase in the total number of spots was observed among the marked transheterozygous (MH) flies. Through analysis of balancer heterozygous (BH) descendants, recombinogenic effects were observed at all concentrations in descendants of the HB cross. In view of these experimental conditions and results, it was concluded that Pantoprazole is associated with recombinogenic effects in Drosophila melanogaster.
Introduction
Pantoprazole [5 -(difluoromethoxy -2 -[[(3,4-dimethoxy-2-pyridinyl ) methyl] sulfinyl]-1H-benzimidazol] is a weakly basic "prodrug" which accumulates in highly acidic environments and becomes rapidly activated in cationic sulfonamide (Raffin et al., 2007; Vishvakarma and Singh, 2011) . According to Stupnicki et al. (2004) , it has a low potential for metabolic interaction with cytochrome P450 (CYP450) oxidation systems and is, for this reason, especially suitable for patients treated with other medications. Mathews et al. (2010) found that Pantoprazole is completely metabolized by the hepatic cytochrome P450 system, and more than 80% of the inactive metabolites are eliminated via renal excretion. Yeo et al. (2008) tested the effects of several drugs used in the treatment of gastric cell tumors. They demonstrated that the cytotoxic effect of Pantoprazole triggers mitochondria-dependent apoptosis in the cells of the tumor.
The long-term use of Pantoprazole, however, may result in hypergastrinemia, possible hyperplasia of the cells of the enteric nervous system, carcinoid tumors of the stomach, liver cell adenoma and other carcinomas as well as thyroid neoplasms (Pantoloc, 2003) .
Genetic toxicology is an important field that studies the genotoxic/mutagenic properties of agents (chemical, physical and biological) to which organisms are exposed, using various assays to assess the damage that these may cause to DNA in the presence or absence of mass metabolic systems. These assays include the SMART (Somatic Mutation and Recombination Test) developed by Graf et al. (1984) . The use of SMART on Drosophila melanogaster wings can detect a wide spectrum of genetic abnormalities, such as mutation, deletion and recombination (Graf et al., 1984) . The test is based on the fact that during early embryonic development of D. melanogaster, groups of cells composing imaginal discs proliferate mitotically until during metamorphosis they become differentiated into body structures of the adult fly. If there is a genetic alteration in an imaginal wing disc, a clone of mutant cells will be formed and detected as a spot on the wings of the mutant adult fly (Guzmán-Rincón and Graf, 1995) . The analysis of these spots determines the phenotypic expression of the marker genes flr 3 or mwh, responsible for changes in the shape of wing hairs or trichomes (Graf et al., 1984) .
The worldwide growing consumption of Pantoprazole and easy access to this drug, which no longer requires a medical prescription, have generated increased interest in assessing possible genotoxic effects associated with its use. Hence, the objective of the present study was to evaluate genotoxic effects of Pantoprazole by applying the Drosophila melanogaster wing spot test. Differences in the levels of cytochrome P450 on Pantoprazole genotoxic activity was evaluated by way of standard (ST) and highbioactivation (HB) crosses of Drosophila. An HB cross is characterized by an increased cytochrome P450-dependent bioactivation capacity for promutagens when compared with an ST cross. For testing with SMART (Graf et al., 1984) , mutant strains of D. melanogaster were provided by Dr. Urich Graf of the Institute of Toxicology, University of Zurich, Schwerzenbach, Switzerland. Three mutant strains of Drosophila melanogaster with genetic markers were used in the study: multiple wing hairs (mwh, 3-0.33), flare-3 (flr 3 , 3-38.8 ) and ORR; flare-3 (ORR; flr 3 ). Stocks of these strains were kept in a BOD incubator 411D New Ethics (Nova Ética Indústria Comércio e Serviços Ltda, São Paulo, Brazil) at a temperature of about 25°C ± 2 and 60% humidity in 250 mL flasks containing a medium prepared with 820 mL of water, 11 g agar, 156 g of banana, 1 g of nipagin (Fagron do Brasil Farmacêutica, São Paulo, Brazil) and 25 g of biological yeast Saccharomyces cerevisiae. Eggs were collected for a period of 8 h in flasks containing solid agar (4% agar in water) and a layer of yeast (S. cerevisiae) supplemented with sugar. After 72 ± 4 h, the third instar larvae were washed with reverse osmosis water and collected in a fine mesh steel sieve. Groups of approximately 100 larvae were transferred to glass tubes (2.5 cm in diameter and 8.0 cm in height) containing 1.5 g of a culture medium of instant mashed potatoes (HIKARI ® , São Paulo Brazil) and 5.0 mL of each of three concentrations of the agent to be tested. The emerging adult flies were collected and stored in 70% ethanol.
Material and Methods

Chemical compounds
The 72-hour old larvae from both crosses (ST and HB) were transferred to 2.5 cm x 8.0 cm high glass tubes containing 1.5 g of instant mashed potatoes with three concentrations of Pantoprazole: 2.5 mM, 5.0 mM or 10.0 mM. The larvae subsequently continued on to develop through the pupal stage (48 h). Reverse osmosis water was used as a solvent and negative control and doxorubicin (DXR, 0.4 mM) as a positive control. DXR was used as positive control, because in SMART assays with D. melanogaster it was classified as a strong mutagen, inducing all types of wing spots (Orsolin et al., 2012) .
Preparation and microscopic analysis of the wings
The wings of adult flies preserved in 70% ethanol were removed with entomological forceps under a stereomicroscope. They were soaked in Faure solution (30 g of gum arabic, 20 mL of glycerol, 1.5 g chloral hydrate and 50 mL distilled water), and stretched on slides. The slides were dried for approximately 2 h on a hot plate (40°C). Finally, a cover slip was applied and the wings were coded. Wing spot analysis was performed using a light optical microscope at 400X magnification (40x). The number, types (single or twin), position and size of the spots were calculated and recorded. Approximately 48,000 cells were analyzed per fly.
Statistical analysis
Statistical analysis of the experiment was performed using a chi square test as described by Frei and Würgler (1988) . The non-parametric U test of Mann-Whitney and a Wilcoxon test were used to exclude false positive results.
For the analysis of anti-mutagenicity, the frequencies of each type of spot were compared in pairs, using the U test (Frei and Würgler, 1995) at a significance level of a = 0.05.
Results and Discussion
All of the compounds were tested in two different experiments. The data were pooled after verifying that the two independent experiments were in agreement with acceptable reproducibility. No significant decreases in the survival rates of larvae submitted to treatments were observed when compared to the negative control. The maximum concentration used in our study corresponded to plasma levels found in patients treated with single oral dose of 40 mg of Pantoprazole (Kamdi and Palkar, 2013) . The maximum values found by the authors were seen at 2 h 56 min after exposure. Table 1 shows the results of mutant spot frequencies observed in the BH and MH descendants of the Standard Cross (ST), treated with Pantoprazole in three different concentrations (2.5, 5.0 or 10.0 mM). The positive control (DXR 0.4 mM) and negative control (reverse osmosis water) are also presented. Table 2 shows the results of mutant spot frequencies observed in the BH and MH descendants of the high bioactivation cross (HB), for the same concentrations of Pantoprazole, as well as the positive and negative controls.
When compared to the negative control, Pantoprazole caused a significant increase in the frequency of small, simple spots at all concentrations. The total number of spots, however, was only statistically significant at 2.5 and 5.0 mM. Results for the HB cross in terms of the potential mutagenic properties of Pantoprazole are presented in Table 2. The total number of mutant spots among the MH descendants, compared to the negative control, was significantly increased in all concentrations.
The analysis of flies with the BH genotype (mwh/TM3) was carried out for the purpose of calculating the portion of recombinogenic and mutagenic events. It is possible to separate mutational events from recombinational events, because recombinational events are eliminated in flies with this genotype. A comparison of cloneinduction frequencies obtained for Pantoprazole in both genotypes indicated that in ST flies, 49.76% of mutant clones produced by Pantoprazole were due to mutation and 50.24% due to recombination at the 2.5 mM concentration. Clone-induction frequencies for Pantoprazole (5.0 mM) indicated that 52.85% of the mutant clones produced were due to mutation and 47.15% to recombination. However, the very same analysis showed that in HB flies, 31.30% of spots induced by Pantoprazole (2.5 mM) were due to mutation and 68.70% to recombination; 37.56% of spots induced by Pantoprazole (5.0 mM) were due to mutation and 62.44% to recombination; 35.48% mutant clones produced by Pantoprazole (10 mM) were due to mutation and 64.52 to recombination. Thus, our results indicate that recombinogenicity was the major genotoxic effect of Pantoprazole in HB flies.
Many compounds are converted to highly reactive metabolites by oxidative enzymes, principally cytochrome P450. Thus, by introducing one or more hydroxyl groups on a substrate, a pre-carcinogen can become a carcinogen (Gregory, 1986) . The genetic control of xenobiotic metabolism in Drosophila is complex, and multiple forms of P450 as well as other enzymes (e.g., amine oxidases) are known to be involved in the activation of certain promutagens (Frölich and Würgler, 1989) . According to our findings, Pantoprazole has a clear recombinogenic potential in Drosophila, and the stock differences demonstrate a strong dependence on levels of metabolic activation (HB flies) as the increased cytochrome P450-dependent biocativation capacity present in these HB larvae leads to significantly increased recombinogenicity. Therefore, the metabolic pathway in the induction of recombinogenicity most probably involves cytochrome P450-dependent enzyme activity. In accordance with these findings, Mathews et al. (2010) showed that Pantoprazole is completely metabolized by the hepatic cytochrome P450 system. Although homologous recombination is an important pathway in DNA repair, there is growing evidence that deleterious genomic rearrangements may result from homologous recombination, which means that homologous recombination events may play a causative role in carcinogenesis (Arossi et al., 2009) . The transformation of normal cells into cancer cells is a multistep process, and mitotic recombination can be a mechanism involved in such transformation (Nowell, 1976; Barrett, 1993) . In heterozygous cells bearing a mutant and normal alleles for a tumor suppressor gene, somatic recombination may turn out to be a promoter of neoplasms by inducing homozygosis of the mutant tumor suppressor allele (Maher et al., 1993; Sengstag, 1994) . Kuipers (2006) has stated that prolonged use of proton pump inhibitors (PPIs) may be related to the development of gastric cancer. It is also known that treatment with PPIs does not protect against this type of cancer, but the increased risk of cancer due to prolonged use remains unknown. Thomson et al. (2010) have reported that among patients diagnosed as negative for H. pylori and without pre-existing gastritis, PPIs did not cause chronic gastritis. In contrast, people infected by H. pylori were found to have chronic, persistent gastritis, atrophy and metaplasia, which may progress to gastric atrophy, intestinal metaplasia and gastric cancer. PPIs used in the treatment of this infection may also cause an acceleration of the progression or development of gastritis (Thomson et al., 2010) . Nonetheless, until now there is no evidence that PPIs increase the risk of gastric cancer. Persistent, predominant gastritis and atrophic gastritis of the gastric body mucosa, however, are considered important risk factors for the development of Including rare single flr gastric cancer, and, clearly, more studies are needed to reach a definitive conclusion (Kuipers, 2006) . Chen et al. (2012) showed that Pantoprazole pretreatment could enhance the anti-tumor effects of adriamycin on xenografted tumor in nude mice and also improve the apoptotic index in xenografted tumor tissues. According to the authors, Pantoprazole pretreatment enhances the cytotoxic effects of anti-tumor drugs on human gastric adenocarcinoma cells (SGC7901) and reverts multidrug resistance of SGC7901/ADR cells by down-regulating the V-ATPases/mTOR/HIF-1a/P-gp and MRP1 signaling pathway. Shen et al. (2013) also showed that pantoprazole inhibits the proliferation and induced apoptosis of SGC7901 human gastric cancer cells. Finally, according to Patel et al. (2013) , the use of Pantoprazole to enhance the distribution and cytotoxicity of anticancer drugs in solid tumors might be a novel treatment strategy to improve their therapeutic indices.
By means of in vivo experiments
It is worthy of note that tests for mutagenic evaluation are generally limited to such specific effects and that not every change in genetic material is a mutation. For this reason, SMART is an important tool for mutagenic assessment. It provides an evaluation of mutational events, as well as recombinogenic events, as shown in the present study. It is known that substances that cause DNA damage also induce recombination, which generates more DNA damage (Hoffman, 1994) . Recombination can promote loss of heterozygosity in somatic cells and germ cells which, in turn, may influence cancer progression (Happle, 1999) . Brambilla et al. (2010) reviewed the genotoxic and carcinogenic effects of 71 gastrointestinal drugs, demonstrating that Pantoprazole was found to be genotoxic and carcinogenic in several assays, in addition to causing chromosomal damage. These results are consistent with those presented herein, where Pantoprazole caused an increase in the frequency of mutant spots for somatic cells, revealing its genotoxic characteristics. The genotoxicity of a particular substance is, thus, not exclusively caused by its association with mutation but also with recombination events, which may cause chromosomal damage. At current, the published studies are conflicting in their results, warranting further examination by means of additional assays and test organisms.
In conclusion, the present study indicates that Pantoprazole possesses recombinogenic activity in the Drosophila wing spot test. Nonetheless, although there was an increase in mutant spots in the ST descendants, the increase in recombinogenic activity was observed only in the high bioactivation (HB) descendants, this suggesting the interaction of their constituents (Pantoprazole) with cytochrome P450.
